EGAGenomicsN/Ahttps://ega-archive.org/datasets/EGAD0001000193624EGA dataset EGAD00010001936EGANeoplasias, primary cancer, MT, Benign, Malignant Neoplasm, microarray., malignant neoplasm, Malignancy, Neoplasms, Neoplasm, Benign Neoplasm, Malignancies, Benign Neoplasms, Cancers, Tumor, other neoplasm, Malignant, malignant tumor, Neoplasia, Cancer, Tumors, Malignant NeoplasmsAdenocarcinoma, Dimethyl, Methane, colon tumor, Colon Neoplasm, malignant neoplasm of colon, insensitive, Colon Adenocarcinomas, Neoplasms, Gene, dimethylsulfoxyde, Rimso 100, Colon Cancer, autosomal dominant, colon neoplasm, malignant colonic neoplasm, Sulphoxide, sensitive, Colon Neoplasms, malignant tumor of colon, malignant tumour of colon, prevention and control, sensitivity, malignant tumor of the colon, Rheumabene, malignant colon tumour, S(O)Me2, treatment, sulfinylbis(methane), Gene Expressions, Colonic, reference sample, dimethyl sulphoxide, prevention., Colonic Cancer, Cancer of the Colon, Expressions, large intestine cancer, Rimso-50, allergic reaction, preventive measures, malignant colon tumor, dimetil sulfoxido, malignant colonic tumour, Rimso, Dimethylsulphinyl, Dimethylsulfoxide, malignant neoplasm of the colon, disease management, Therapies, Expression, cancer of colon, somatic mutation, Dimethylsulfoxid, Controlled, Cancer, Therapy, sulfinylbis-, Controlling, DMSO, preventive therapy, dimethyli sulfoxidum, dmso, malignant, methylsulfinylmethane, Colon Adenocarcinoma, Adenocarcinomas, (CH3)2SO, Colonic Cancers, Dimexide, Dimethylsulphoxide, Neoplasm, malignant colonic tumor, CRC, Sulfoxide, Sulfinylbis(methane), Rimso 50, Colon Cancers, resistant, Rimso50, prophylaxis, susceptibility to, Colonic Neoplasm, Colon cancer, dimethyl sulfoxide, Sclerosol, Dimethyl Sulphoxide, Cancers, Colon, Treatments, colon cancer, Cancer of Colon, Therapeutic, control, malignant tumour of the colon, Treatment, dimethyl sulfur oxide, malignant colon neoplasmfalseColorectal-Cancer-Tumor-Spheres-H012-Microarray_ExpressionGene expression of 12 colon cancer TSCs (sensitive or resistant) after 12h treatment with 3µM NCT02 or DMSO (control) was analyzed using Illumina microarrays (HumanHT-12 v4 BeadChip).2020-08-10 15:57:25EGAD000100019369606EGAC00001000452EGAS00001004517